<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="5" ids="15940">Nicotinic acid</z:chebi> <z:chebi fb="1" ids="16708">adenine</z:chebi> <z:chebi fb="0" ids="47885">dinucleotide</z:chebi> phosphate (NAADP) is the most potent <z:chebi fb="0" ids="29108">Ca2+</z:chebi> releasing second messenger known to date </plain></SENT>
<SENT sid="1" pm="."><plain>Here we report a new role for NAADP in arrhythmogenic <z:chebi fb="0" ids="29108">Ca2+</z:chebi> release in cardiac myocytes evoked by β-adrenergic stimulation </plain></SENT>
<SENT sid="2" pm="."><plain>Infusion of NAADP into intact cardiac myocytes induced global <z:chebi fb="0" ids="29108">Ca2+</z:chebi> signals sensitive to inhibitors of both acidic <z:chebi fb="0" ids="29108">Ca2+</z:chebi> stores and <z:chebi fb="0" ids="8925">ryanodine</z:chebi> receptors and to NAADP <z:chebi fb="68" ids="48706">antagonist</z:chebi> BZ194 </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, in electrically paced cardiac myocytes BZ194 blocked spontaneous diastolic <z:chebi fb="0" ids="29108">Ca2+</z:chebi> transients caused by high concentrations of the β-<z:chebi fb="0" ids="37886">adrenergic agonist</z:chebi> <z:chebi fb="0" ids="6046">isoproterenol</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="29108">Ca2+</z:chebi> transients were recorded both as increases of the free cytosolic <z:chebi fb="0" ids="29108">Ca2+</z:chebi> concentration and as decreases of the sarcoplasmic <z:chebi fb="2" ids="8069">luminal</z:chebi> <z:chebi fb="0" ids="29108">Ca2+</z:chebi> concentration </plain></SENT>
<SENT sid="5" pm="."><plain>Importantly, NAADP <z:chebi fb="68" ids="48706">antagonist</z:chebi> BZ194 largely ameliorated <z:chebi fb="0" ids="6046">isoproterenol</z:chebi>-induced <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> in awake mice </plain></SENT>
<SENT sid="6" pm="."><plain>We provide strong evidence that NAADP-mediated modulation of couplon activity plays a role for triggering (i) spontaneous diastolic <z:chebi fb="0" ids="29108">Ca2+</z:chebi> transients in isolated cardiac myocytes and (ii) <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> in the intact animal </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, NAADP signalling appears an attractive novel target for antiarrhythmic therapy </plain></SENT>
</text></document>